Abstract
Background
18F fluoro-D-glucose (18F-FDG) positron emission tomography/computed tomography (PET/CT) pharmacokinetics is an approach for efficiently quantifying perfusion and metabolic processes in the liver, but the conventional single-individual optimization algorithms and single-population optimization algorithms have difficulty obtaining reasonable physiological characteristics from estimated parameters. A prior-based multi-population multi-objective optimization (p-MPMOO) approach using two sub-populations based on two categories of prior information was preliminarily proposed for estimating the 18F-FDG PET/CT pharmacokinetics of patients with hepatocellular carcinoma.
Methods
PET data from 24 hepatocellular carcinoma (HCC) tumors of 5-min dynamic PET/CT supplemented with 1-min static PET at 60 min were prospectively collected. A reversible double-input three-compartment model and kinetic parameters (K1, k2, k3, k4, fa, and \(\:{v}_{b}\)) were used to quantify the metabolic information. The single-individual Levenberg–Marquardt (LM) algorithm, single-population algorithms (Particle Swarm Optimization (PSO), Differential Evolution (DE), and Genetic Algorithm (GA)) and p-MPMO optimization algorithms (p-MPMOPSO, p-MPMODE, and p-MPMOGA) were used to estimate the parameters.
Results
The areas under the curve (AUCs) of the three p-MPMO methods were significantly higher than other methods in K1 and k4 (P < 0.05 in the DeLong test) and the single population optimization in k2 and k3 (P < 0.05), and did not differ from other methods in fa and vb (P > 0.05). Compared with single-population optimization, the three p-MPMO methods improved the significant differences between K1, k2, k3, and k4. The p-MPMOPSO showed significant differences (P < 0.05) in the parameter estimation of k2, k3, k4, and fa. The p-MPMODE is implemented on K1, k2, k3, k4, and fa; The p-MPMOGA does it on all six parameters.
Conclusions
The p-MPMOO approach proposed in this paper performs well for distinguishing HCC tumors from normal liver tissue.
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer




